Nachrichten zur GW Pharmaceuticals PLC (ADRs) Aktie

GW Pharmaceuticals plc. (GWPH) CEO Justin Gover on 39th Annual JPMorgan Virtual Healthcare Conference - (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW PHARMACEUTICALS PLC: 8-K Report

8-K...…

GW Pharmaceuticals foresees Q4 revenue above consensus

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharmaceuticals provides upbeat total and Epidiolex sales outlooks; stock declines

GW Pharmaceuticals PLC provided an upbeat outlook for fourth-quarter sales, amid strength in sales of Epidiolex, the first cannabis-based…

CORRECTING and REPLACING - GW Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference

LONDON and CARLSBAD, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- In a release issued earlier today by GW Pharmaceuticals…

GW Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference

LONDON and CARLSBAD, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company…

Intec Pharma jumps 65% after research pact with UK based GW Pharma

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Intec Pharma Announces Cannabinoid Research Collaboration with GW Pharma

Um den gesamten Artikel unter barchart.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharmaceuticals to Present at the 2020 Needham Virtual Epilepsy & Pain – Specialty CNS Therapeutics Conference

LONDON and CARLSBAD, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company…

PreMarket Prep Stock Of The Day: GW Pharmaceuticals

Benzingas PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to…

GW Pharmaceuticals to Present at the Evercore ISI 2020 Healthcare Conference

LONDON and CARLSBAD, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company…

GW Pharmaceuticals plc (GWPH) CEO Justin Gover presents at Stifel Virtual Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharmaceuticals: Buy This Stock With Strong Guidance And A Solid Pipeline

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharmaceuticals to Present at the Stifel 2020 Virtual Healthcare Conference

LONDON and CARLSBAD, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company…

GW Pharmaceuticals Plc Remains A Solid Growth Story

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW PHARMACEUTICALS PLC: 10-Q Report

10-Q...…

GW Pharmaceuticals initiates phase 3 study of Nabiximols for multiple sclerosis-associated spasticity

Nabiximols, known as Sativex outside of the U.S. and approved for use to treat MS spasticity in over 25 countries,…

GW Pharmaceuticals PLC (GWPH) Q3 2020 Earnings Call Transcript

GWPH earnings call for the period ending September 30, 2020....…

GW Pharma shares rally on earnings and news of late-stage trial of cannabis-based treatment for MS patients

Shares of GW Pharmaceuticals PLC jumped 18% Tuesday, after the biotech posted a narrower-than-expected third-quarter loss and a revenue beat…

How GW Pharmaceuticals Blew Away Expectations With Its Q3 Results

Momentum for Epidiolex remains very strong....…

GW Pharmaceuticals Initiates Phase 3 Trial for Multiple Sclerosis Drug

The cannabinoid prescription drug Sativex has already been approved in numerous countries for reducing spasticity caused by MS....…

Inspire Medical Systems, GW Pharmaceuticals leads healthcare gainers; Esperion Therapeutics, Aurinia Pharmaceuticals among major losers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW PHARMACEUTICALS PLC: 8-K Report

8-K...…

Should you invest in Alibaba, Charles Schwab, GW Pharmaceuticals, UnitedHealth Group, or Uber?

NEW YORK , Nov. 3, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BABA,…

GW Pharmaceuticals up 6.4% on Q3 beat

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharma launches late-stage study of nabiximols in MS-associated spasticity

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharmaceuticals loss narrows more than expected and revenue beats; stock rallies

Shares of GW Pharmaceuticals PLC rallied 4.7% in premarket trading Tuesday, after the biopharmaceutical company developing therapeutics from its…

GW Pharmaceuticals EPS beats by $0.02, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharmaceuticals stock set to rally after Phase 3 trial of MS treatment to start, after COVID-19-related delay

Shares of GW Pharmaceuticals PLC were indicated up more than 6% in premarket trading Tuesday, after the biopharmaceutical company…

GW Pharmaceuticals plc Reports Third Quarter 2020 Financial Results and Operational Progress

- Total revenue increased 51 percent to $137.1 million – - Epidiolex for seizures associated with TSC launched in the U.S.…

GW Pharmaceuticals stock set to rally after initiation of Phase 3 trial of MS treatment

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharmaceuticals Initiates Pivotal Phase 3 Study of Nabiximols for Multiple Sclerosis-Associated Spasticity

CARLSBAD, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the…

GW Pharmaceuticals Q3 2020 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Earnings Season Could Be Great for GW Pharmaceuticals (GWPH)

GW Pharmaceuticals (GWPH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings…

GW Pharmaceuticals Q3 Earnings May Provide Clarity On Many Issues

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Third Quarter Ending September 30th, 2020 and Host Conference Call on November 3rd, 2020

LONDON and CARLSBAD, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the…

The Daily Biotech Pulse: Coronavirus Vaccine Updates From J&J & MediciNova, Australian Regulatory Nod For GW Pharma

Heres a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week…

GW Pharmaceuticals: Buy the Dip?

The stock has fallen more than 20% in just the past three months....…

GW Pharmaceuticals receives Australian Therapeutic Goods Administration (TGA) approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy

This represents the third successful regulatory approval globally for GWs plant-derived cannabis-based medicine This represents the third successful regulatory approval…

GW Pharmaceuticals plc (GWPH) CEO Justin Gover Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…